China Pharma Holdings Files 10-Q for Q1 2025
Ticker: CPHI · Form: 10-Q · Filed: May 14, 2025 · CIK: 1106644
| Field | Detail |
|---|---|
| Company | China Pharma Holdings, Inc. (CPHI) |
| Form Type | 10-Q |
| Filed Date | May 14, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, quarterly-report, pharmaceuticals
TL;DR
China Pharma Holdings filed its Q1 2025 10-Q. All systems go.
AI Summary
China Pharma Holdings, Inc. filed its 10-Q for the quarterly period ended March 31, 2025. The company, incorporated in Nevada, is in the pharmaceutical preparations industry. Its principal executive offices are located in Haikou, Hainan Province, China.
Why It Matters
This filing provides investors with an update on China Pharma Holdings' financial performance and operational status for the first quarter of 2025.
Risk Assessment
Risk Level: low — This is a routine quarterly filing with no immediate red flags or significant new information.
Key Players & Entities
- CHINA PHARMA HOLDINGS, INC. (company) — Registrant
- March 31, 2025 (date) — Quarterly period end date
- 001-34471 (company) — Commission File Number
- 75-1564807 (company) — IRS Employer Identification No.
- Nevada (company) — State of incorporation
FAQ
What is the primary business of China Pharma Holdings, Inc.?
China Pharma Holdings, Inc. is in the business of Pharmaceutical Preparations, as indicated by its Standard Industrial Classification code [2834].
When was the quarterly period covered by this 10-Q filing?
The quarterly period ended on March 31, 2025.
Where are the principal executive offices of China Pharma Holdings, Inc. located?
The principal executive offices are located at Second Floor, No. 17, Jinpan Road, Haikou, Hainan Province, China.
What is the Commission File Number for China Pharma Holdings, Inc.?
The Commission File Number is 001-34471.
What is the IRS Employer Identification Number for China Pharma Holdings, Inc.?
The IRS Employer Identification Number is 75-1564807.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 14, 2025 regarding CHINA PHARMA HOLDINGS, INC. (CPHI).